Biopool Completes Sale of Division to Georgia Firm
- Share via
Biopool International in Ventura has completed the sale of its blood bank reagent business to Immucor Inc. of Norcross, Ga.
The sale resulted in a cash payment of about $4.45 million, a figure that may be adjusted based upon actual assets transferred. Biopool has retained ownership of the plant, property and equipment in the West Chester, Pa., facility and will operate the facility on behalf of Immucor during a transition period.
Biopool expects to generate significant liquidity from this transaction and the sale of its West Chester facility in the coming months.
Immucor, founded in 1982, manufactures and sells products used by hospitals, reference laboratories and donor centers to detect and identify certain properties in blood before transfusion.
Founded in 1987, Biopool develops and manufactures test kits to assess and diagnose blood disorders and toxicology controls used to monitor and measure the presence of drugs of abuse.
The company’s products are sold to hospitals, clinical laboratories, commercial reference laboratories and research institutions.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
